NCT00656422

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: University Hospital Tuebingen · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The main objective of this clinical trial is to investigate hepatic fat as the primary endpoint along with body fat, and weight changes after initiation of a basal insulin therapy together with data acquisition that is today's standard in studies investigating obesity and eating patterns with insulin detemir and insulin glargine.

Conditions

• Diabetes
• Obesity

Interventions

Type	Name	Description
DRUG	insulin Levemir	The participant will receive an insulin dose of insulin Levemir at dinner subcutaneously according to a dosing algorithm.
DRUG	insulin Lantus	The participant will receive an insulin dose of the insulin Lantus at dinner subcutaneously according to a dosing algorithm.

Timeline

• Start date: 2007-11-01
• First posted: 2008-04-11
• Last updated: 2012-11-01

Locations

5 sites across 3 countries: Austria, Germany, Switzerland